The USH2A c.2299delG mutation: Dating its common origin in a Southern European population

European Journal of Human Genetics

Volumn 18, Issue 7, 2010, Pages 788-793

  Aller, Elena ^a,b   Larrieu, Lise ^c   Jaijo, Teresa ^a,b   Baux, David ^c   Espinós, Carmen ^b   González Candelas, Fernando ^d,e,f   Nájera, Carmen ^g   Palau, Francesc ^b,h   Claustres, Mireille ^c,i,j   Roux, Anne Françoise ^c,i   Millán, José M ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF VALENCIA   (Spain)

^e CSISP ^*  (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

ⁱ INSERM   (France)

^j UNIV MONTPELLIER   (France)

more..

Author keywords

C.2299delG; Dating; Haplotype; USH2A

Indexed keywords

ISOPROTEIN; PROTEIN USH2A; SCLEROPROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE LOCATION; GENETIC CODE; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN EUROPE; USHER SYNDROME;

ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXTRACELLULAR MATRIX PROTEINS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; USHER SYNDROMES;

EID: 77953810729     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.14     Document Type: Article

References (34)

1. Baux D, Larrieu L, Blanchet C et al: Molecular and in silico analyses of the full length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat 2007; 28: 781-789.
2. Dreyer B, Brox V, Tranebjaerg L et al: Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat 2008; 29: 451.
3. Kimberling WJ: Estimation of the frequency of occult mutations for an autosomal recessive disease in the presence of genetic heterogeneity: application to genetic hearing loss disorders. Hum Mutat 2005; 26: 462-470.
4. Eudy JD, Weston MD, Yao S et al: Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998; 280: 1753-1757.
5. Weston MD, Eudy JD, Fujita S et al: Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000; 66: 1199-1210.
6. Van Wijk E, Pennings RJ, te Brinke H et al: Identification of 51 novel exons of the Usher syndrome type 2a (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet 2004; 74: 738-744.
7. Adato A, Lefèvre G, Delprat B et al: Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. Hum Mol Genet 2005; 14: 3921-3932.
8. Liu X, Bulgakov OV, Darrow KN et al: Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proc Natl Acad Sci USA 2007; 104: 4413-4418.
9. Maerker T, van Wijk E, Overlack N et al: A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum Mol Genet 2008; 17: 71-86.
10. Aller E, Jaijo T, Beneyto M et al: Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet 2006; 43: e55.
11. Auslender N, Bandah D, Rizel L et al: Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews. Genet Test 2008; 12: 289-294.
12. Dai H, Zhang X, Zhao X et al: Identification of five novel mutations in the long isoform of the USH2A gene in Chinese families with Usher syndrome type II. Mol Vis 2008; 14: 2067-2075.
13. Nakanishi H, Ohtsubo M, Iwasaki S et al: Identification of 11 novel mutations in USH2A among Japanese patients with Usher syndrome type 2. Clin Genet 2009; 76: 383-391.
14. Baux D, Faugère V, Larrieu L et al: UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes. Hum Mutat 2008; 29: E76-E87.
15. Pennings RJ, Te Brinke H, Weston MD et al: USH2A mutation analysis in 70 Dutch families with Usher syndrome type II. Hum Mutat 2004; 24: 185.
16. Liu XZ, Hope C, Liang CY et al: A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and henotypic variation. Am J Hum Genet 1999; 64: 1221-1225.
17. Leroy BP, Aragon-Martin JA, Weston MD et al: Spectrum of mutations in USH2A in British patients with Usher syndrome type II. Exp Eye Res 2001; 72: 503-509.
18. Dreyer B, Tranebjaerg L, Brox V et al: A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet 2001; 69: 228-234.
19. Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
20. Bandelt H-J, Forster P, Röhl A: Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 1999; 16: 37-48.
21. Slatkin M, Rannala B: Estimating the age of alleles by use of intraallelic variability. Am J Hum Genet 1997; 60: 447-458.
22. Rannala B, Slatkin M: Likelihood analysis of disequilibrium mapping, and related problems. Am J Hum Genet 1998; 62: 459-473.
23. Reeve JP, Rannala B: DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002; 18: 894-895.
24. Rannala B, Reeve JP: Joint Bayesian estimation of mutation location and age using linkage disequilibrium. Pac Symp Biocomput 2003; 526-534.
25. Bengtsson BO, Thomson G: Measuring the strength of associations between HLA antigens and diseases. Ti s s u e A n t i g e n s 1981; 18: 356-363.
26. Sorensen DA, Gianola D: Likelihood, Bayesian and MCMC Methods in Quantitative Genetics. New York: Springer-Verlag, 2002.
27. Luria SE, Delbrück M: Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28: 491-511.
28. Labuda M, Labuda D, Korab-Laskowska M et al: Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet 1996; 59: 633-643.
29. Labuda D, Zietkiewicz E, Labuda M: The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim. Am J Hum Genet 1997; 61: 768-771.
30. Colombo R: Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: a reappraisal of haplotype data. Am J Hum Genet 2000; 66: 692-697.
31. Fenner JN: Cross-cultural estimation of the human generation interval for use in genetics-based population divergence studies. Am J Phys Anthropol 2005; 128: 415-423.
32. Myers S, Freeman C, Auton A, Donnelly P, McVean G: A common sequence motif associated with recombination hot spots and genome instability in humans. Nat Genet 2008; 40: 1124-1129.
33. Adato A, Weston MD, Berry A, Kimberling WJ, Bonne-Tamir A: Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. Hum Mutat 2000; 15: 388.
34. Kaiserman N, Obolensky A, Banin E, Sharon D: Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2. Arch Ophthalmol 2007; 125: 219-224.